Duvall Diantha 4

What Happened
Diantha Duvall, Chief Financial Officer of Curis, received a derivative equity award on July 7, 2026: an option grant covering 48,285 shares with an exercise price of $5.29 (48,285 x $5.29 = $255,428). This was reported on an SEC Form 4 filed July 9, 2026.

Key Details

• Transaction type: Award/Grant of options (code A — derivative).
• Transaction date: July 7, 2026; Filing date: July 9, 2026.
• Shares involved: 48,285 option shares; exercise price per share: $5.29; nominal total = $255,428.
• Vesting: 25% vests July 7, 2027, then 6.25% of the original shares each quarter thereafter until July 7, 2030 (footnote F1).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Exhibit: 24.1 Power of Attorney attached.

Context
This was an equity compensation grant (options) rather than an open-market buy or sale; the options vest over time and must be exercised (and likely held or sold) later to convert into shares. Such grants are standard executive compensation and do not by themselves indicate immediate buying or selling of stock.